Prices delayed by at least 15 minutes | Print
Maxcyte INC (MXCT)
COM STK USD0.01 (DI)Open
211.00p
Previous close
212.00p
Trade high
212.00p
Volume
15,002
Year high
410.00p
Year low
177.00p
Dividend yield
–
Market capitalisation
£224.78 mn
P/E ratio
–
ISIN
US57777K1060
This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Dividend reinvestment
Share price
Company profile
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.
News
Recent trades
Date | Time | Price | Quantity | Value (£) |
---|---|---|---|---|
25/04/2025 | 04:38:59 | 212 | 7,500 | 15,900.00 |
25/04/2025 | 04:35:18 | 212 | 7,500 | 15,900.00 |
25/04/2025 | 03:32:18 | 207.8 | 1 | 2.08 |
25/04/2025 | 03:32:17 | 210 | 1 | 2.10 |
24/04/2025 | 04:35:02 | 212 | 5,000 | 10,600.00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.